Safety Profile of the Respiratory Fluoroquinolone Moxifloxacin: Comparison with Other Fluoroquinolones and Other Antibacterial Classes

Author： >   Tulkens Paul M.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.32, Iss.5, 2009-01, pp. : 359-378

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety Reporting and Adverse-Event Profile of Mirtazapine Described in Randomized Controlled Trials in Comparison with Other Classes of Antidepressants in the Acute-Phase Treatment of Adults with Depression: Systematic Review and Meta-Analysis

By Watanabe Norio  

CNS Drugs, Vol. 24, Iss. 1, 2010-01 ,pp. : 35-53

Adis International

Access to resources Recommend Favorite

Safety Profile of the Fluoroquinolones: Focus on Levofloxacin

By Liu Hans H.  

Drug Safety, Vol. 33, Iss. 5, 2010-05 ,pp. : 353-369

Adis International

Access to resources Recommend Favorite

Moxifloxacin in respiratory tract infections

By Miravitlles Marc  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 2, 2005-02 ,pp. : 283-293

Informa Healthcare

Access to resources Recommend Favorite

Antibacterial Activity of Lipophilic Fluoroquinolone Derivatives

By  

Medicinal Chemistry, Vol. 5, Iss. 5, 2009-09 ,pp. : 419-421

Bentham Science Publishers

Access to resources Recommend Favorite

Safety Profile of the Fluoroquinolones: Analysis of Adverse Drug Reactions in Relation to Prescription Data Using Four Regional Pharmacovigilance Databases in Italy

By Lapi Francesco   Tuccori Marco   Motola Domenico  

Drug Safety, Vol. 33, Iss. 9, 2010-09 ,pp. : 789-799

Adis International

Access to resources Recommend Favorite